Skip to content

Lifecore Biomedical, Inc. LFCR Current maturities of long-term debt

Current maturities of long-term debt at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Labcorp Holdings logo
Labcorp HoldingsLH
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s current maturities of long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s current maturities of long-term debt?
Lifecore Biomedical, Inc. (LFCR) reported current maturities of long-term debt of $189K in Q1 2026.
How has Lifecore Biomedical, Inc.'s current maturities of long-term debt changed year-over-year?
Lifecore Biomedical, Inc.'s current maturities of long-term debt increased by 15.2% year-over-year, from $164K to $189K.
What is the long-term trend for Lifecore Biomedical, Inc.'s current maturities of long-term debt?
Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s current maturities of long-term debt has grown at a 9.3% compound annual growth rate (CAGR), from $121K to $189K.